U
University of Rochester | UR Dermatology at College Town
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
PF-04965842
Dupilumab
CTP-543
Parent organization
This site is a part of University of Rochester
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...
Active, not recruiting
Alopecia Areata
Drug: CTP-543
This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a to...
Enrolling
Alopecia Areata
Drug: Placebo
Drug: Dupilumab
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg
Trial sponsors
E
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems